Stay updated on Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial

Sign up to get notified when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page

  1. Check
    11 days ago
    No Change Detected
  2. Check
    19 days ago
    Change Detected
    Summary
    Added Study Status and Recruitment Status entries, including Terminated and Sponsor decision dated 2026-02-23 and 2026-02-20. The previous 'Active, not recruiting' status from 2024-08-01 was removed.
    Difference
    0.8%
    Check dated 2026-02-26T14:50:24.000Z thumbnail image
  3. Check
    33 days ago
    Change Detected
    Summary
    Added revision v3.4.2 to the record history and removed v3.4.1. These are minor maintenance changes that do not affect study data or user-facing content.
    Difference
    0.1%
    Check dated 2026-02-12T02:50:40.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The record history shows a new revision entry v3.4.1 and removal of v3.4.0, indicating a minor update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T01:26:10.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    UI text and labeling updates include the addition of a 'Show glossary' label, color-coding explanations for additions and deletions, and a new 'Revision: v3.4.0' tag, with capitalization tweaks like 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T22:22:26.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision v3.3.4 was added to the study record history. Revision v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T07:34:52.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-24T02:24:02.000Z thumbnail image

Stay in the know with updates to Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.